{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADME", "immune response", "medicinal plants", "microglia polarization", "neuroinflammation", "neurological diseases", "target production"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35214883", "DateRevised": {"Year": "2022", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "18"}], "Language": ["eng"], "ELocationID": ["549", "10.3390/plants11040549"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "18"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile.", "Abstract": {"AbstractText": ["Neurodegenerative diseases (NDs) are one of the most challenging public health issues. Despite tremendous advances in our understanding of NDs, little progress has been made in establishing effective treatments. Natural products may have enormous potential in preventing and treating NDs by targeting microglia; yet, there have been several clinical concerns about their usage, primarily due to a lack of scientific evidence for their efficacy, molecular targets, physicochemical properties, and safety. To solve this problem, the secondary bioactive metabolites derived from neuroprotective medicinal plants were identified and selected for computational predictions for anti-inflammatory activity, possible molecular targets, physicochemical properties, and safety evaluation using PASS online, Molinspiration, SwissADME, and ProTox-II, respectively. Most of the phytochemicals were active as anti-inflammatory agents as predicted using the PASS online webserver. Moreover, the molecular target predictions for some phytochemicals were similar to the reported experimental targets. Moreover, the phytochemicals that did not violate important physicochemical properties, including blood-brain barrier penetration, GI absorption, molecular weight, and lipophilicity, were selected for further safety evaluation. After screening 54 neuroprotective phytochemicals, our findings suggest that Aromatic-turmerone, Apocynin, and Matrine are the most promising compounds that could be considered when designing novel neuroprotective agents to treat neurodegenerative diseases via modulating microglial polarization."]}, "AuthorList": [{"Identifier": ["0000-0002-2770-218X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia."}, {"Identifier": [], "Affiliation": "King Abdullah International Medical Research Centre (KAIMRC), Ministry of National Guard Health Affairs, Riyadh 11481, Saudi Arabia."}], "LastName": "Alghamdi", "ForeName": "Sahar Saleh", "Initials": "SS"}, {"Identifier": ["0000-0002-6323-0781"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia."}, {"Identifier": [], "Affiliation": "King Abdullah International Medical Research Centre (KAIMRC), Ministry of National Guard Health Affairs, Riyadh 11481, Saudi Arabia."}], "LastName": "Suliman", "ForeName": "Rasha Saad", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia."}], "LastName": "Aljammaz", "ForeName": "Norah Abdulaziz", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia."}], "LastName": "Kahtani", "ForeName": "Khawla Mohammed", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia."}], "LastName": "Aljatli", "ForeName": "Dimah Abdulqader", "Initials": "DA"}, {"Identifier": ["0000-0001-5657-4650"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11474, Saudi Arabia."}], "LastName": "Albadrani", "ForeName": "Ghadeer M", "Initials": "GM"}], "GrantList": [{"GrantID": "SP21R/463/12", "Agency": "King Abdullah International Medical Research Center", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chen L., Deng H., Cui H., Fang J., Zuo Z., Deng J., Li Y., Wang X., Zhao L. Inflammatory Responses and Inflammation-Associated Diseases in Organs.  [(accessed on 14 December 2017)];Oncotarget. 2018 9:7204. doi: 10.18632/oncotarget.23208. Available online:  https://www.oncotarget.com/article/23208/text/", "ArticleIdList": ["10.18632/oncotarget.23208", "PMC5805548", "29467962"]}, {"Citation": "Ferrero-Miliani L., Nielsen O.H., Andersen P.S., Girardin S.E. Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1\u03b2 generation.  [(accessed on 26 December 2021)];Clin. Exp. Immunol. 2017 147:227\u2013235. doi: 10.1111/j.1365-2249.2006.03261.x. Available online:  https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2249.2006.03261.x.", "ArticleIdList": ["10.1111/j.1365-2249.2006.03261.x", "10.1111/j.1365-2249.2006.03261.x", "PMC1810472", "17223962"]}, {"Citation": "Nathan C., Ding A.  Nonresolving Inflammation. Volume 140. Elsevier; Amsterdam, The Netherlands: 2010.  [(accessed on 31 May 2021)]. pp. 871\u2013882. Available online:  https://pubmed.ncbi.nlm.nih.gov/20303877/", "ArticleIdList": ["20303877"]}, {"Citation": "Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., Russell R.I. Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs.  [(accessed on 13 February 2021)];N. Engl. J. Med. 1992 327:749\u2013754. doi: 10.1056/NEJM199209103271101. Available online:  https://pubmed.ncbi.nlm.nih.gov/1501650/", "ArticleIdList": ["10.1056/NEJM199209103271101", "1501650"]}, {"Citation": "McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains.  [(accessed on 26 December 2021)];Neurology. 1988 38:1285\u20131291. doi: 10.1212/WNL.38.8.1285. Available online:  https://pubmed.ncbi.nlm.nih.gov/3399080/", "ArticleIdList": ["10.1212/WNL.38.8.1285", "3399080"]}, {"Citation": "Banati R.B., Daniel S.E., Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Mov. Disord. 1998 13:221\u2013227. doi: 10.1002/mds.870130205. Available online:  https://pubmed.ncbi.nlm.nih.gov/9539333/", "ArticleIdList": ["10.1002/mds.870130205", "9539333"]}, {"Citation": "Raine C.S. Multiple Sclerosis: Immune System Molecule Expression in the Central Nervous System.  [(accessed on 26 December 2021)];J. Neuropathol. Exp. Neurol. 1994 53:328\u2013337. doi: 10.1097/00005072-199407000-00002. Available online:  https://pubmed.ncbi.nlm.nih.gov/8021705/", "ArticleIdList": ["10.1097/00005072-199407000-00002", "8021705"]}, {"Citation": "Zhonghua L., Dong W., Sheng Z., Ye B., Za Z., Zhonghua L., Weisheng Z.Z. Chinese Journal of Industrial Hygiene and Occupational Diseases Publons.  [(accessed on 26 December 2021)].  Available online:  https://publons.com/journal/18134/zhonghua-lao-dong-wei-sheng-zhi-ye-bing-za-zhi-zho/"}, {"Citation": "Magni P., Ruscica M., Dozio E., Rizzi E., Beretta G., Facino R.M. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-\u03b1 and NF-\u03baB nuclear translocation in BV-2 microglia. Phyther. Res. 2012;26:1405\u20131409. doi: 10.1002/ptr.3732.", "ArticleIdList": ["10.1002/ptr.3732", "22359368"]}, {"Citation": "Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.  [(accessed on 26 December 2021)];Proc. Natl. Acad. Sci. USA. 1989 86:7611\u20137615. doi: 10.1073/pnas.86.19.7611. Available online:  https://pubmed.ncbi.nlm.nih.gov/2529544/", "ArticleIdList": ["10.1073/pnas.86.19.7611", "PMC298116", "2529544"]}, {"Citation": "N\u00e4slund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.  [(accessed on 26 December 2021)];JAMA. 2000 283:1571\u20131577. doi: 10.1001/jama.283.12.1571. Available online:  https://pubmed.ncbi.nlm.nih.gov/10735393/", "ArticleIdList": ["10.1001/jama.283.12.1571", "10735393"]}, {"Citation": "Jia Y., Zhao G., Jia J. Preliminary evaluation: The effects of Aloe ferox Miller and Aloe arborescens Miller on wound healing.  [(accessed on 3 April 2021)];J. Ethnopharmacol. 2008 120:181\u2013189. doi: 10.1016/j.jep.2008.08.008. Available online:  https://pubmed.ncbi.nlm.nih.gov/18773950/", "ArticleIdList": ["10.1016/j.jep.2008.08.008", "18773950"]}, {"Citation": "Hale C., V\u00e9niant M., Wang Z., Chen M., McCormick J., Cupples R., Hickman D., Min X., Sudom A., Xu H., et al.  Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.  [(accessed on 26 December 2021)];Chem. Biol. Drug. Des. 2008 71:36\u201344. doi: 10.1111/j.1747-0285.2007.00603.x. Available online:  https://pubmed.ncbi.nlm.nih.gov/18069989/", "ArticleIdList": ["10.1111/j.1747-0285.2007.00603.x", "18069989"]}, {"Citation": "Lee D.C., Rizer J., Selenica M.-L.B., Reid P., Kraft C., Johnson A., Blair L., Gordon M.N., Dickey C., Morgan D. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.  [(accessed on 26 December 2021)];J. Neuroinflamm. 2010 7:56. doi: 10.1186/1742-2094-7-56. Available online:  https://jneuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-7-56.", "ArticleIdList": ["10.1186/1742-2094-7-56", "10.1186/1742-2094-7-56", "PMC2949628", "20846376"]}, {"Citation": "Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration.  [(accessed on 26 December 2021)];Cell. 2010 140:918\u2013934. doi: 10.1016/j.cell.2010.02.016. Available online:  https://pubmed.ncbi.nlm.nih.gov/20303880/", "ArticleIdList": ["10.1016/j.cell.2010.02.016", "PMC2873093", "20303880"]}, {"Citation": "Braak H., del Tredici K., R\u00fcb U., de Vos R.J., Steur E.N.H., Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Neurobiol Aging. 2003 24:197\u2013211. doi: 10.1016/S0197-4580(02)00065-9. Available online:  https://pubmed.ncbi.nlm.nih.gov/12498954/", "ArticleIdList": ["10.1016/S0197-4580(02)00065-9", "12498954"]}, {"Citation": "Rocha N.P., de Miranda A.S., Teixeira A.L. Insights into neuroinflammation in Parkinson\u2019s disease: From biomarkers to anti-inflammatory based therapies. Biomed. Res. Int. 2015;2015:628192. doi: 10.1155/2015/628192.", "ArticleIdList": ["10.1155/2015/628192", "PMC4532803", "26295044"]}, {"Citation": "Ouchi Y., Yoshikawa E., Sekine Y., Futatsubashi M., Kanno T., Ogusu T., Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Ann. Neurol. 2005 57:168\u2013175. doi: 10.1002/ana.20338. Available online:  https://pubmed.ncbi.nlm.nih.gov/15668962/", "ArticleIdList": ["10.1002/ana.20338", "15668962"]}, {"Citation": "Frohman E.M., Racke M.K., Raine C.S. Multiple Sclerosis\u2014The Plaque and Its Pathogenesis.  [(accessed on 26 December 2021)];New Engl. J. Med. 2006 354:942\u2013955. doi: 10.1056/NEJMra052130. Available online:  https://www.nejm.org/doi/10.1056/NEJMra052130.", "ArticleIdList": ["10.1056/NEJMra052130", "10.1056/NEJMra052130", "16510748"]}, {"Citation": "Bsibsi M., Peferoen L.A.N., Holtman I.R., Nacken P.J., Gerritsen W.H., Witte M.E., van Horssen J., Eggen B.J.L., van der Valk P., Amor S., et al.  Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-\u03b3 and alpha B-crystallin.  [(accessed on 26 December 2021)];Acta Neuropathol. 2014 128:215\u2013229. doi: 10.1007/s00401-014-1317-8. Available online:  https://pubmed.ncbi.nlm.nih.gov/24997049/", "ArticleIdList": ["10.1007/s00401-014-1317-8", "24997049"]}, {"Citation": "Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis.  [(accessed on 26 December 2021)];Nat. Med. 1999 5:170\u2013175. doi: 10.1038/5532. Available online:  https://pubmed.ncbi.nlm.nih.gov/9930864/", "ArticleIdList": ["10.1038/5532", "9930864"]}, {"Citation": "Askari V.R., Fereydouni N., Baradaran R.V., Askari N., Sahebkar A.H., Rahmanian-Devin P., Samzadeh-Kermani A. \u03b2-Amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide/interferon-\u03b3 and regulates M\u03c6 1/M\u03c6 2 balances.  [(accessed on 26 December 2021)];Biomed. Pharmacother. 2018 101:438\u2013446. doi: 10.1016/j.biopha.2018.02.098. Available online:  https://pubmed.ncbi.nlm.nih.gov/29501766/", "ArticleIdList": ["10.1016/j.biopha.2018.02.098", "29501766"]}, {"Citation": "Correa F., Hernang\u00f3mez M., Mestre L., Lor\u00eda F., Spagnolo A., Docagne F., Guaza C. Anandamide enhances IL-10 production in activated microglia by targeting CB2 receptors: Roles of ERK1/2, JNK, and NF-kappaB.  [(accessed on 26 December 2021)];Glia. 2010 58:135\u2013147. doi: 10.1002/glia.20907. Available online:  https://pubmed.ncbi.nlm.nih.gov/19565660/", "ArticleIdList": ["10.1002/glia.20907", "19565660"]}, {"Citation": "Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: Time for reassessment.  [(accessed on 26 December 2021)];F1000Prime Rep. 2014 6:13. doi: 10.12703/P6-13. Available online:  http://pmc/articles/PMC3944738/", "ArticleIdList": ["10.12703/P6-13", "PMC3944738", "24669294"]}, {"Citation": "Tay T.L., Carrier M., Tremblay M.\u00c8. Physiology of microglia. Adv. Exp. Med. Biol. 2019;1175:129\u2013148.", "ArticleIdList": ["31583587"]}, {"Citation": "Solanki I., Parihar P., Parihar M.S. Neurodegenerative diseases: From available treatments to prospective herbal therapy.  [(accessed on 26 December 2021)];Neurochem. Int. 2016 95:100\u2013108. doi: 10.1016/j.neuint.2015.11.001. Available online:  https://pubmed.ncbi.nlm.nih.gov/26550708/", "ArticleIdList": ["10.1016/j.neuint.2015.11.001", "26550708"]}, {"Citation": "Dur\u00e3es F., Pinto M., Sousa E. Old Drugs as New Treatments for Neurodegenerative Diseases.  [(accessed on 26 December 2021)];Pharmaceuticals. 2018 11:44.  doi: 10.3390/ph11020044. Available online:  https://www.mdpi.com/1424-8247/11/2/44/htm.", "ArticleIdList": ["10.3390/ph11020044", "PMC6027455", "29751602"]}, {"Citation": "Beard C.M., Kokmen E., O\u2019Brien P.C., Kurland L.T. The prevalence of dementia is changing over time in Rochester, Minnesota.  [(accessed on 26 December 2021)];Neurology. 1995 45:75\u201379. doi: 10.1212/WNL.45.1.75. Available online:  https://pubmed.ncbi.nlm.nih.gov/7824140/", "ArticleIdList": ["10.1212/WNL.45.1.75", "7824140"]}, {"Citation": "Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer\u2019s disease in the United States and the public health impact of delaying disease onset.  [(accessed on 26 December 2021)];Am. J. Public. Health. 1998 88:1337\u20131342. doi: 10.2105/AJPH.88.9.1337. Available online:  https://pubmed.ncbi.nlm.nih.gov/9736873/", "ArticleIdList": ["10.2105/AJPH.88.9.1337", "PMC1509089", "9736873"]}, {"Citation": "The Tacrine Study Group\u2014PubMed  A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer\u2019s disease.  [(accessed on 26 December 2021)];JAMA. 1994 27:985\u2013991. Available online:  https://pubmed.ncbi.nlm.nih.gov/8139083/", "ArticleIdList": ["8139083"]}, {"Citation": "Larochelle A., Bellavance M.A., Rivest S. Role of adaptor protein MyD88 in TLR-mediated preconditioning and neuroprotection after acute excitotoxicity. Brain Behav. Immun. 2015;46:221\u2013231. doi: 10.1016/j.bbi.2015.02.019.", "ArticleIdList": ["10.1016/j.bbi.2015.02.019", "25733102"]}, {"Citation": "Bachiller S., Jim\u00e9nez-Ferrer I., Paulus A., Yang Y., Swanberg M., Deierborg T., Boza-Serrano A. Microglia in neurological diseases: A road map to brain-disease dependent-inflammatory response. Front. Cell Neurosci. 2018;12:488. doi: 10.3389/fncel.2018.00488.", "ArticleIdList": ["10.3389/fncel.2018.00488", "PMC6305407", "30618635"]}, {"Citation": "Turner M.D., Nedjai B., Hurst T., Pennington D.J. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta-Mol. Cell Res. 2014;1843:2563\u20132582. doi: 10.1016/j.bbamcr.2014.05.014.", "ArticleIdList": ["10.1016/j.bbamcr.2014.05.014", "24892271"]}, {"Citation": "Rodr\u00edguez-G\u00f3mez J.A., Kavanagh E., Engskog-Vlachos P., Engskog M.K.R., Herrera A.J., Espinosa-Oliva A.M. Microglia: Agents of the CNS Pro-Inflammatory Response.  [(accessed on 26 December 2021)];Cells. 2020 9:1717.  doi: 10.3390/cells9071717. Available online:  https://www.mdpi.com/2073-4409/9/7/1717/htm.", "ArticleIdList": ["10.3390/cells9071717", "PMC7407646", "32709045"]}, {"Citation": "He P., Yan S., Zheng J., Gao Y., Zhang S., Liu Z., Liu X., Xiao C. Eriodictyol Attenuates LPS-Induced Neuroinflammation, Amyloidogenesis, and Cognitive Impairments via the Inhibition of NF-\u03baB in Male C57BL/6J Mice and BV2 Microglial Cells.  [(accessed on 26 December 2021)];J. Agric. Food Chem. 2018 66:10205\u201310214. doi: 10.1021/acs.jafc.8b03731. Available online:  https://pubmed.ncbi.nlm.nih.gov/30208700/", "ArticleIdList": ["10.1021/acs.jafc.8b03731", "30208700"]}, {"Citation": "Li Q., Chen L., Liu X., Li X., Cao Y., Bai Y., Qi F. Pterostilbene inhibits amyloid-\u03b2-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway.  [(accessed on 26 December 2021)];J. Cell Biochem. 2018 119:7053\u20137062. doi: 10.1002/jcb.27023. Available online:  https://pubmed.ncbi.nlm.nih.gov/29737568/", "ArticleIdList": ["10.1002/jcb.27023", "29737568"]}, {"Citation": "Yang H., Chen Y., Yu L., Xu Y. Esculentoside A exerts anti-inflammatory activity in microglial cells. Int. Immunopharmacol. 2017;51:148\u2013157. doi: 10.1016/j.intimp.2017.08.014.", "ArticleIdList": ["10.1016/j.intimp.2017.08.014", "28843178"]}, {"Citation": "Shi X., Zheng Z., Li J., Xiao Z., Qi W., Zhang A., Wu Q., Fang Y. Curcumin inhibits A\u03b2-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways.  [(accessed on 26 December 2021)];Neurosci. Lett. 2015 594:105\u2013110. doi: 10.1016/j.neulet.2015.03.045. Available online:  https://www.meta.org/papers/curcumin-inhibits-a-induced-microglial/25818332.", "ArticleIdList": ["10.1016/j.neulet.2015.03.045", "25818332"]}, {"Citation": "Jin M., Park S.Y., Shen Q., Lai Y., Ou X., Mao Z., Lin D., Yu Y., Zhang W. Anti-neuroinflammatory effect of curcumin on Pam3CSK4-stimulated microglial cells.  [(accessed on 26 December 2021)];Int. J. Mol. Med. 2018 41:521\u2013530. doi: 10.3892/ijmm.2017.3217. Available online:  https://pubmed.ncbi.nlm.nih.gov/29115589/", "ArticleIdList": ["10.3892/ijmm.2017.3217", "29115589"]}, {"Citation": "Liu Z.-J., Li Z.-H., Liu L., Tang W.-X., Wang Y., Dong M.-R., Xiao C. Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer\u2019s Disease.  [(accessed on 26 December 2021)];Front. Pharmacol. 2016 7:1\u201312. doi: 10.3389/fphar.2016.00261. Available online:  https://pubmed.ncbi.nlm.nih.gov/27594837/", "ArticleIdList": ["10.3389/fphar.2016.00261", "PMC4990744", "27594837"]}, {"Citation": "Park S.Y., Jin M.L., Kim Y.H., Kim Y., Lee S.J. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-\u03baB, JNK, and p38 MAPK signaling pathways in amyloid \u03b2-stimulated microglia.  [(accessed on 26 December 2021)];Int. Immunopharmacol. 2012 14:13\u201320. doi: 10.1016/j.intimp.2012.06.003. Available online:  https://pubmed.ncbi.nlm.nih.gov/22728094/", "ArticleIdList": ["10.1016/j.intimp.2012.06.003", "22728094"]}, {"Citation": "Park S.Y., Kim Y.H., Kim Y., Lee S.J. Aromatic-turmerone\u2019s anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling.  [(accessed on 26 December 2021)];Neurochem. Int. 2012 61:767\u2013777. doi: 10.1016/j.neuint.2012.06.020. Available online:  https://pubmed.ncbi.nlm.nih.gov/22766494/", "ArticleIdList": ["10.1016/j.neuint.2012.06.020", "22766494"]}, {"Citation": "Chen M., Chang Y.Y., Huang S., Xiao L.H., Zhou W., Zhang L.Y., Li C., Zhou R.P., Tang J., Lin L., et al.  Aromatic-Turmerone Attenuates LPS-Induced Neuroinflammation and Consequent Memory Impairment by Targeting TLR4-Dependent Signaling Pathway.  [(accessed on 26 December 2021)];Mol. Nutr. Food Res. 2018 62:1700281. doi: 10.1002/mnfr.201700281. Available online:  https://pubmed.ncbi.nlm.nih.gov/28849618/", "ArticleIdList": ["10.1002/mnfr.201700281", "28849618"]}, {"Citation": "Candelario-Jalil E., de Oliveira A.C.P., Gr\u00e4f S., Bhatia H.S., H\u00fcll M., Mu\u00f1oz E., Fiebich B.L. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia.  [(accessed on 26 December 2021)];J. Neuroinflamm. 2007 4:25. doi: 10.1186/1742-2094-4-25. Available online:  https://pmc/articles/PMC2100038/", "ArticleIdList": ["10.1186/1742-2094-4-25", "PMC2100038", "17927823"]}, {"Citation": "Capiralla H., Vingtdeux V., Zhao H., Sankowski R., Al-Abed Y., Davies P., Marambaud P. Resveratrol mitigates lipopolysaccharide- and A\u03b2-mediated microglial inflammation by inhibiting the TLR4/NF-\u03baB/STAT signaling cascade.  [(accessed on 26 December 2021)];J. Neurochem. 2012 120:461\u2013472. doi: 10.1111/j.1471-4159.2011.07594.x. Available online:  https://pubmed.ncbi.nlm.nih.gov/22118570/", "ArticleIdList": ["10.1111/j.1471-4159.2011.07594.x", "PMC3253186", "22118570"]}, {"Citation": "Hou Y., Xie G., Miao F., Ding L., Mou Y., Wang L., Wu C. Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice.  [(accessed on 26 December 2021)];Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014 54:92\u2013102. doi: 10.1016/j.pnpbp.2014.03.015. Available online:  https://pubmed.ncbi.nlm.nih.gov/24709550/", "ArticleIdList": ["10.1016/j.pnpbp.2014.03.015", "24709550"]}, {"Citation": "Subedi L., Lee J.H., Yumnam S., Ji E., Kim S.Y. Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-\u03baB Inhibition and Nrf2/HO-1 Activation. Cells. 2019;8:194. doi: 10.3390/cells8020194.", "ArticleIdList": ["10.3390/cells8020194", "PMC6406309", "30813369"]}, {"Citation": "Hou T.T., Yang H.Y., Wang W., Wu Q.Q., Tian Y.R., Jia J.P. Sulforaphane Inhibits the Generation of Amyloid-\u03b2 Oligomer and Promotes Spatial Learning and Memory in Alzheimer\u2019s Disease [PS1V97L] Transgenic Mice.  [(accessed on 26 December 2021)];J. Alzheimers Dis. 2018 62:1803\u20131813. doi: 10.3233/JAD-171110. Available online:  https://pubmed.ncbi.nlm.nih.gov/29614663/", "ArticleIdList": ["10.3233/JAD-171110", "29614663"]}, {"Citation": "Kim C.Y., Lee C., Park G.H., Jang J.H. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.  [(accessed on 26 December 2021)];Arch. Pharm. Res. 2009 32:869\u2013881. doi: 10.1007/s12272-009-1609-z. Available online:  https://pubmed.ncbi.nlm.nih.gov/19557365/", "ArticleIdList": ["10.1007/s12272-009-1609-z", "19557365"]}, {"Citation": "Cheng-Chung W.J., Huang H.C., Chen W.J., Huang C.N., Peng C.H., Lin C.L. Epigallocatechin gallate attenuates amyloid \u03b2-induced inflammation and neurotoxicity in EOC 13.31 microglia.  [(accessed on 26 December 2021)];Eur. J. Pharmacol. 2016 770:16\u201324. doi: 10.1016/j.ejphar.2015.11.048. Available online:  https://pubmed.ncbi.nlm.nih.gov/26643169/", "ArticleIdList": ["10.1016/j.ejphar.2015.11.048", "26643169"]}, {"Citation": "Lee Y.J., Choi D.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties.  [(accessed on 26 December 2021)];J. Nutr. Biochem. 2013 24:298\u2013310. doi: 10.1016/j.jnutbio.2012.06.011. Available online:  https://pubmed.ncbi.nlm.nih.gov/22959056/", "ArticleIdList": ["10.1016/j.jnutbio.2012.06.011", "22959056"]}, {"Citation": "Seo J.Y., Pyo E., An J.P., Kim J., Sung S.H., Oh W.K. Andrographolide Activates Keap1/Nrf2/ARE/HO-1 Pathway in HT22 Cells and Suppresses Microglial Activation by A \u03b242 through Nrf2-Related Inflammatory Response.  [(accessed on 26 December 2021)];Mediat. Inflamm. 2017 2017:5906189. Available online:  https://pubmed.ncbi.nlm.nih.gov/28373747/", "ArticleIdList": ["PMC5360972", "28373747"]}, {"Citation": "Wang T., Liu B., Zhang W., Wilson B., Hong J.S. Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation.  [(accessed on 26 December 2021)];J. Pharmacol. Exp. Ther. 2004 308:975\u2013983. doi: 10.1124/jpet.103.059683. Available online:  https://pubmed.ncbi.nlm.nih.gov/14718612/", "ArticleIdList": ["10.1124/jpet.103.059683", "14718612"]}, {"Citation": "Yang R., Liu S., Zhou J., Bu S., Zhang J. Andrographolide attenuates microglia-mediated A\u03b2 neurotoxicity partially through inhibiting NF-\u03baB and JNK MAPK signaling pathway.  [(accessed on 26 December 2021)];Immunopharmacol. Immunotoxicol. 2017 39:276\u2013284. doi: 10.1080/08923973.2017.1344989. Available online:  https://pubmed.ncbi.nlm.nih.gov/28669260/", "ArticleIdList": ["10.1080/08923973.2017.1344989", "28669260"]}, {"Citation": "Liu H., Wang J., Wang J., Wang P., Xue Y. Paeoniflorin attenuates A\u03b21-42-induced inflammation and chemotaxis of microglia in vitro and inhibits NF-\u03baB- and VEGF/Flt-1 signaling pathways. Brain Res. 2015;1618:149\u2013158. doi: 10.1016/j.brainres.2015.05.035.", "ArticleIdList": ["10.1016/j.brainres.2015.05.035", "26049130"]}, {"Citation": "Luo X.Q., Li A., Yang X., Xiao X., Hu R., Wang T.W., Dong Z. Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2.  [(accessed on 26 December 2021)];Chin. Med. 2018 13:1\u201317. doi: 10.1186/s13020-018-0173-1. Available online:  https://pubmed.ncbi.nlm.nih.gov/29560022/", "ArticleIdList": ["10.1186/s13020-018-0173-1", "PMC5859430", "29560022"]}, {"Citation": "Askari V.R., Shafiee-Nick R. The protective effects of \u03b2-caryophyllene on LPS-induced primary microglia M 1/M 2 imbalance: A mechanistic evaluation.  [(accessed on 26 December 2021)];Life Sci. 2019 219:40\u201373. doi: 10.1016/j.lfs.2018.12.059. Available online:  https://pubmed.ncbi.nlm.nih.gov/30620895/", "ArticleIdList": ["10.1016/j.lfs.2018.12.059", "30620895"]}, {"Citation": "Cheng Y., Dong Z., Liu S. \u03b2-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPAR\u03b3 pathway.  [(accessed on 26 December 2021)];Pharmacology. 2014 94:1\u201312. doi: 10.1159/000362689. Available online:  https://pubmed.ncbi.nlm.nih.gov/25171128/", "ArticleIdList": ["10.1159/000362689", "25171128"]}, {"Citation": "Zhang Z.Y., Daniels R., Schluesener H.J. Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis.  [(accessed on 26 December 2021)];J. Cell Mol. Med. 2013 17:1566\u20131576. doi: 10.1111/jcmm.12124. Available online:  https://pubmed.ncbi.nlm.nih.gov/24034629/", "ArticleIdList": ["10.1111/jcmm.12124", "PMC3914648", "24034629"]}, {"Citation": "Wang S., Yang H., Yu L., Jin J., Qian L., Zhao H., Zhu X. Oridonin attenuates A\u03b21-42-induced neuroinflammation and inhibits NF-\u03baB pathway.  [(accessed on 26 December 2021)];PLoS ONE. 2014 9:e104745.  doi: 10.1371/journal.pone.0104745. Available online:  https://pubmed.ncbi.nlm.nih.gov/25121593/", "ArticleIdList": ["10.1371/journal.pone.0104745", "PMC4133239", "25121593"]}, {"Citation": "Jing N., Li X. Dihydromyricetin Attenuates Inflammation through TLR4/NF-kappaB Pathway.  [(accessed on 26 December 2021)];Open Med. 2019 14:719\u2013725. doi: 10.1515/med-2019-0083. Available online:  https://pubmed.ncbi.nlm.nih.gov/31572805/", "ArticleIdList": ["10.1515/med-2019-0083", "PMC6749725", "31572805"]}, {"Citation": "Sun P., Yin J.-B., Liu L.-H., Guo J., Wang S.-H., Qu C.-H., Wang C.-X. Protective role of Dihydromyricetin in Alzheimer\u2019s disease rat model associated with activating AMPK/SIRT1 signaling pathway.  [(accessed on 26 December 2021)];Biosci. Rep. 2019 39:BSR20180902. doi: 10.1042/BSR20180902. Available online:  https://pmc/articles/PMC6328867/", "ArticleIdList": ["10.1042/BSR20180902", "PMC6328867", "30498091"]}, {"Citation": "Feng J., Wang J., Du Y., Liu Y., Zhang W., Chen J., Liu Y., Zheng M., Wang K., He G. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.  [(accessed on 26 December 2021)];CNS Neurosci. Ther. 2018 24:1207\u20131218. doi: 10.1111/cns.12983. Available online:  https://pubmed.ncbi.nlm.nih.gov/29869390/", "ArticleIdList": ["10.1111/cns.12983", "PMC6282966", "29869390"]}, {"Citation": "Lee Y.J., Choi D.Y., Choi I.S., Kim K.H., Kim Y.H., Kim H.M., Hong J.T. Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models.  [(accessed on 26 December 2021)];J. Neuroinflamm. 2012 9:35. doi: 10.1186/1742-2094-9-35. Available online:  https://pubmed.ncbi.nlm.nih.gov/22339795/", "ArticleIdList": ["10.1186/1742-2094-9-35", "PMC3323460", "22339795"]}, {"Citation": "Jin G., Bai D., Yin S., Yang Z., Zou D., Zhang Z., Li X., Sun Y., Zhu Q. Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice.  [(accessed on 26 December 2021)];Neurosci. Lett. 2016 629:256\u2013261. doi: 10.1016/j.neulet.2016.06.008. Available online:  https://pubmed.ncbi.nlm.nih.gov/27276653/", "ArticleIdList": ["10.1016/j.neulet.2016.06.008", "27276653"]}, {"Citation": "Ho S.C., Kuo C.T. Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel [Citri reticulatae pericarpium]  [(accessed on 26 December 2021)];Food Chem. Toxicol. 2014 71:176\u2013182. doi: 10.1016/j.fct.2014.06.014. Available online:  https://pubmed.ncbi.nlm.nih.gov/24955543/", "ArticleIdList": ["10.1016/j.fct.2014.06.014", "24955543"]}, {"Citation": "Li C., Zug C., Qu H., Schluesener H., Zhang Z. Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice.  [(accessed on 26 December 2021)];Behav. Brain Res. 2015 281:32\u201342. doi: 10.1016/j.bbr.2014.12.012. Available online:  https://pubmed.ncbi.nlm.nih.gov/25510196/", "ArticleIdList": ["10.1016/j.bbr.2014.12.012", "25510196"]}, {"Citation": "Justin-Thenmozhi A., Dhivya B.M., Kiruthika R., Manivasagam T., Borah A. Essa MM. Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3\u03b2 Pathway by Hesperidin in Wistar Rats.  [(accessed on 26 December 2021)];Neurotox. Res. 2018 34:463\u2013476. doi: 10.1007/s12640-018-9904-4. Available online:  https://pubmed.ncbi.nlm.nih.gov/29687202/", "ArticleIdList": ["10.1007/s12640-018-9904-4", "29687202"]}, {"Citation": "Jiao J., Xue B., Zhang L., Gong Y., Li K., Wang H. Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia.  [(accessed on 26 December 2021)];J. Neuroimmunol. 2008 205:32\u201336. doi: 10.1016/j.jneuroim.2008.08.006. Available online:  https://pubmed.ncbi.nlm.nih.gov/19004508/", "ArticleIdList": ["10.1016/j.jneuroim.2008.08.006", "19004508"]}, {"Citation": "Cui Y.-Q., Wang Q., Zhang D.-M., Wang J.-Y., Xiao B., Zheng Y., Wang X.M. Triptolide Rescues Spatial Memory Deficits and Amyloid-\u03b2 Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.  [(accessed on 26 December 2021)];Curr. Alzheimer Res. 2016 13:288\u2013296. doi: 10.2174/156720501303160217122803. Available online:  https://pubmed.ncbi.nlm.nih.gov/26906357/", "ArticleIdList": ["10.2174/156720501303160217122803", "26906357"]}, {"Citation": "Qi Y., Zou L.B., Wang L.H., Jin G., Pan J.J., Chi T.Y., Ji X.F. Xanthoceraside inhibits pro-inflammatory cytokine expression in A\u03b225-35/IFN-\u03b3-stimulated microglia through the TLR2 receptor, MyD88, nuclear factor-\u03baB, and mitogen-activated protein kinase signaling pathways.  [(accessed on 26 December 2021)];J. Pharmacol. Sci. 2013 122:305\u2013317. doi: 10.1254/jphs.13031FP. Available online:  https://www.researchgate.net/publication/256076333_Xanthoceraside_Inhibits_Pro-inflammatory_Cytokine_Expression_in_Ab25-35IFN-g-Stimulated_Microglia_Through_the_TLR2_Receptor_MyD88_Nuclear_Factor-kB_and_Mitogen-Activated_Protein_Kinase_Signaling_Pathw.", "ArticleIdList": ["10.1254/jphs.13031FP", "23966052"]}, {"Citation": "Zhou H., Tai J., Xu H., Lu X., Meng D. Xanthoceraside could ameliorate Alzheimer\u2019s disease symptoms of rats by affecting the gut microbiota composition and modulating the endogenous metabolite levels. Front. Pharmacol. 2019;10:1035. doi: 10.3389/fphar.2019.01035.", "ArticleIdList": ["10.3389/fphar.2019.01035", "PMC6753234", "31572201"]}, {"Citation": "Kim N., Do J., Bae J.S., Jin H.K., Kim J.H., Inn K.S., Lee J.K. Piperlongumine inhibits neuroinflammation via regulating NF-\u03baB signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells.  [(accessed on 26 December 2021)];J. Pharmacol. Sci. 2018 137:195\u2013201. doi: 10.1016/j.jphs.2018.06.004. Available online:  https://pubmed.ncbi.nlm.nih.gov/29970291/", "ArticleIdList": ["10.1016/j.jphs.2018.06.004", "29970291"]}, {"Citation": "Gu S.M., Lee H.P., Ham Y.W., Son D.J., Kim H.Y., Oh K.W., Hong J.T. Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway. NeuroMolecular Med. 2018;20:312\u2013327. doi: 10.1007/s12017-018-8495-9.", "ArticleIdList": ["10.1007/s12017-018-8495-9", "PMC6097046", "29802525"]}, {"Citation": "Yang H., Wang S., Yu L., Zhu X., Xu Y. Esculentoside A suppresses A\u03b2 [1\u201342]-induced neuroinflammation by down-regulating MAPKs pathways in vivo.  [(accessed on 26 December 2021)];Neurol. Res. 2015 37:859\u2013866. doi: 10.1179/1743132815Y.0000000066. Available online:  https://pubmed.ncbi.nlm.nih.gov/26104317/", "ArticleIdList": ["10.1179/1743132815Y.0000000066", "26104317"]}, {"Citation": "Mrvov\u00e1 N., \u0160kand\u00edk M., Kuniakov\u00e1 M., Ra\u010dkov\u00e1 L. Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester.  [(accessed on 26 December 2021)];Neurochem. Int. 2015 90:246\u2013254. doi: 10.1016/j.neuint.2015.09.005. Available online:  https://pubmed.ncbi.nlm.nih.gov/26386394/", "ArticleIdList": ["10.1016/j.neuint.2015.09.005", "26386394"]}, {"Citation": "Rezai-Zadeh K., Ehrhart J., Bai Y., Sanberg P.R., Bickford P., Tan J., Shytle R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression.  [(accessed on 26 December 2021)];J. Neuroinflamm. 2008 5:41. doi: 10.1186/1742-2094-5-41. Available online:  https://pubmed.ncbi.nlm.nih.gov/18817573/", "ArticleIdList": ["10.1186/1742-2094-5-41", "PMC2569027", "18817573"]}, {"Citation": "Gilmore T.D. Introduction to NF-kappaB: Players, pathways, perspectives.  [(accessed on 26 December 2021)];Oncogene. 2006 25:6680\u20136684. doi: 10.1038/sj.onc.1209954. Available online:  https://pubmed.ncbi.nlm.nih.gov/17072321/", "ArticleIdList": ["10.1038/sj.onc.1209954", "17072321"]}, {"Citation": "Lawrence T. The nuclear factor NF-kappaB pathway in inflammation.  [(accessed on 26 December 2021)];Cold Spring Harb. Perspect. Biol. 2009 1 doi: 10.1101/cshperspect.a001651. Available online:  https://pubmed.ncbi.nlm.nih.gov/20457564/", "ArticleIdList": ["10.1101/cshperspect.a001651", "PMC2882124", "20457564"]}, {"Citation": "Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle.  [(accessed on 26 December 2021)];Cell. 2002 109((Suppl. 1)):S81\u2013S96. doi: 10.1016/S0092-8674(02)00703-1. Available online:  https://pubmed.ncbi.nlm.nih.gov/11983155/", "ArticleIdList": ["10.1016/S0092-8674(02)00703-1", "11983155"]}, {"Citation": "Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-\u03baB activity. Annu. Rev. Immunol. 2000;18:621\u2013663. doi: 10.1146/annurev.immunol.18.1.621.", "ArticleIdList": ["10.1146/annurev.immunol.18.1.621", "10837071"]}, {"Citation": "Sunphenon EGCg [Epigallocatechin-Gallate] in the Early Stage of Alzheimer\u00b4s Disease\u2014Full Text View\u2014ClinicalTrials.Gov.  [(accessed on 26 December 2021)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT00951834."}, {"Citation": "Kaminska B., Mota M., Pizzi M. Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation.  [(accessed on 26 December 2021)];Biochim. Biophys. Acta. 2016 1862:339\u2013351. doi: 10.1016/j.bbadis.2015.10.026. Available online:  https://pubmed.ncbi.nlm.nih.gov/26524636/", "ArticleIdList": ["10.1016/j.bbadis.2015.10.026", "26524636"]}, {"Citation": "Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases.  [(accessed on 26 December 2021)];Brain Res. Bull. 2012 87:10\u201320. doi: 10.1016/j.brainresbull.2011.10.004. Available online:  https://pubmed.ncbi.nlm.nih.gov/22024597/", "ArticleIdList": ["10.1016/j.brainresbull.2011.10.004", "22024597"]}, {"Citation": "Resveratrol for Alzheimer\u2019s Disease\u2014Full Text View\u2014ClinicalTrials.Gov.  [(accessed on 26 December 2021)]; Available online:  https://clinicaltrials.gov/ct2/show/NCT01504854."}, {"Citation": "Skerrett R., Malm T., Landreth G. Nuclear receptors in neurodegenerative diseases.  [(accessed on 26 December 2021)];Neurobiol. Dis. 2014 72:104\u2013116. doi: 10.1016/j.nbd.2014.05.019. Available online:  https://pubmed.ncbi.nlm.nih.gov/24874548/", "ArticleIdList": ["10.1016/j.nbd.2014.05.019", "PMC4246019", "24874548"]}, {"Citation": "Zhao Q., Wu X., Yan S., Xie X., Fan Y., Zhang J., Peng C., You Z. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPAR\u03b3-mediated alteration of microglial activation phenotypes.  [(accessed on 26 December 2021)];J. Neuroinflammation. 2016 13:259. doi: 10.1186/s12974-016-0728-y. Available online:  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0728-y.", "ArticleIdList": ["10.1186/s12974-016-0728-y", "10.1186/s12974-016-0728-y", "PMC5051050", "27716270"]}, {"Citation": "Ringman J.M., Frautschy S.A., Teng E., Begum A.N., Bardens J., Beigi M., Cole G.M. Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.  [(accessed on 26 December 2021)];Alzheimer Res. Ther. 2012 4:43. doi: 10.1186/alzrt146. Available online:  https://clinicaltrials.gov/ct2/show/NCT00099710.", "ArticleIdList": ["10.1186/alzrt146", "PMC3580400", "23107780"]}, {"Citation": "Baum L., Lam C.W.K., Cheung S.K.K., Kwok T., Lui V., Tsoh J., Mok V. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.  [(accessed on 26 December 2021)];J. Clin. Psychopharmacol. 2008 28:110\u2013113. doi: 10.1097/jcp.0b013e318160862c. Available online:  https://clinicaltrials.gov/ct2/show/NCT00164749.", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Yamanaka M., Ishikawa T., Griep A., Axt D., Kummer M.P., Heneka M.T. PPAR\u03b3/RXR\u03b1-induced and CD36-mediated microglial amyloid-\u03b2 phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.  [(accessed on 26 December 2021)];J. Neurosci. 2012 32:17321\u201317331. doi: 10.1523/JNEUROSCI.1569-12.2012. Available online:  https://pubmed.ncbi.nlm.nih.gov/23197723/", "ArticleIdList": ["10.1523/JNEUROSCI.1569-12.2012", "PMC6621845", "23197723"]}, {"Citation": "Savage J.C., Jay T., Goduni E., Quigley C., Mariani M.M., Malm T., Ransohoff R.M., Lamb B.T., Landreth G.E. Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer\u2019s disease.  [(accessed on 26 December 2021)];J. Neurosci. 2015 35:6532\u20136543. doi: 10.1523/JNEUROSCI.4586-14.2015. Available online:  https://pubmed.ncbi.nlm.nih.gov/25904803/", "ArticleIdList": ["10.1523/JNEUROSCI.4586-14.2015", "PMC4405560", "25904803"]}, {"Citation": "Yang Y., Jiang S., Yan J., Li Y., Xin Z., Lin Y., Qu Y. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.  [(accessed on 26 December 2021)];Cytokine Growth Factor Rev. 2015 26:47\u201357. doi: 10.1016/j.cytogfr.2014.09.002. Available online:  https://pubmed.ncbi.nlm.nih.gov/25280871/", "ArticleIdList": ["10.1016/j.cytogfr.2014.09.002", "25280871"]}, {"Citation": "Holtman I.R., Skola D., Glass C.K. Transcriptional control of microglia phenotypes in health and disease. [(accessed on 26 December 2021)];J. Clin. Invest. 2017 127:3220\u20133229. doi: 10.1172/JCI90604. doi: 10.1172/JCI90604. Available online:", "ArticleIdList": ["10.1172/JCI90604", "10.1172/JCI90604", "PMC5669536", "28758903"]}, {"Citation": "Koistinaho M., Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia.  [(accessed on 26 December 2021)];Glia. 2002 40:175\u2013183. doi: 10.1002/glia.10151. Available online:  https://pubmed.ncbi.nlm.nih.gov/12379905/", "ArticleIdList": ["10.1002/glia.10151", "12379905"]}, {"Citation": "Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: Actions and mechanisms of action.  [(accessed on 26 December 2021)];Trends Neurosci. 1995 18:130\u2013136. doi: 10.1016/0166-2236(95)93890-A. Available online:  https://pubmed.ncbi.nlm.nih.gov/7754524/", "ArticleIdList": ["10.1016/0166-2236(95)93890-A", "7754524"]}, {"Citation": "Hanisch U.K. Microglia as a source and target of cytokines. Glia. 2002;40:140\u2013155. doi: 10.1002/glia.10161.", "ArticleIdList": ["10.1002/glia.10161", "12379902"]}, {"Citation": "Sedgwick J.D., Riminton D.S., Cyster J.G., K\u00f6rner H. Tumor necrosis factor: A master-regulator of leukocyte movement.  [(accessed on 26 December 2021)];Immunol. Today. 2000 21:110\u2013113. doi: 10.1016/S0167-5699(99)01573-X. Available online:  https://pubmed.ncbi.nlm.nih.gov/10689296/", "ArticleIdList": ["10.1016/S0167-5699(99)01573-X", "10689296"]}, {"Citation": "Hussain G., Rasul A., Anwar H., Sohail M.U., Kamran S.K.S., Baig S.M., Shabbir A. Epidemiological Data of Neurological Disorders in Pakistan and Neighboring Countries: A Review.  [(accessed on 26 December 2021)];Pak. J. Neurol. Sci. 2017 12:52\u201370. Available online:  https://ecommons.aku.edu/pjns/vol12/iss4/12."}, {"Citation": "Kaur R., Mehan S., Singh S. Understanding multifactorial architecture of Parkinson\u2019s disease: Pathophysiology to management.  [(accessed on 26 December 2021)];Neurol. Sci. 2019 40:13\u201323. doi: 10.1007/s10072-018-3585-x. Available online:  https://pubmed.ncbi.nlm.nih.gov/30267336/", "ArticleIdList": ["10.1007/s10072-018-3585-x", "30267336"]}, {"Citation": "Thanvi B., Lo N., Robinson T. Levodopa-induced dyskinesia in Parkinson\u2019s disease: Clinical features, pathogenesis, prevention and treatment.  [(accessed on 26 December 2021)];Postgrad. Med. J. 2007 83:384\u2013388. doi: 10.1136/pgmj.2006.054759. Available online:  https://pubmed.ncbi.nlm.nih.gov/17551069/", "ArticleIdList": ["10.1136/pgmj.2006.054759", "PMC2600052", "17551069"]}, {"Citation": "Rui W., Li S., Xiao H., Xiao M., Shi J. Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/Caspase-1/GSDMD Pathway in MPTP-Induced Mice Model of Parkinson\u2019s Disease.  [(accessed on 26 December 2021)];Int. J. Neuropsychopharmacol. 2020 23:762\u2013773. doi: 10.1093/ijnp/pyaa060. Available online:  https://academic.oup.com/ijnp/article/23/11/762/5881996.", "ArticleIdList": ["10.1093/ijnp/pyaa060", "PMC7745250", "32761175"]}, {"Citation": "Fan Z., Liang Z., Yang H., Pan Y., Zheng Y., Wang X. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia. J. Neuroinflamm. 2017;14:256. doi: 10.1186/s12974-017-1036-x.", "ArticleIdList": ["10.1186/s12974-017-1036-x", "PMC5738892", "29262843"]}, {"Citation": "Baek J.Y., Jeong J.Y., Kim K.I., Won S.-Y., Chung Y.C., Nam J., Cho E.J., Ahn T.-B., Bok E., Shin W.-H., et al.  Inhibition of Microglia-Derived Oxidative Stress by Ciliary Neurotrophic Factor Protects Dopamine Neurons In Vivo from MPP+ Neurotoxicity.  [(accessed on 26 December 2021)];Int. J. Mol. Sci. 2018 19:3543.  doi: 10.3390/ijms19113543. Available online:  https://pubmed.ncbi.nlm.nih.gov/30423807/", "ArticleIdList": ["10.3390/ijms19113543", "PMC6274815", "30423807"]}, {"Citation": "Bok E., Chung Y.C., Kim K.S., Baik H.H., Shin W.H., Jin B.K. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.  [(accessed on 26 December 2021)];Exp. Mol. Med. 2018 50:1\u201314. doi: 10.1038/s12276-018-0111-4. Available online:  https://www.nature.com/articles/s12276-018-0111-4.", "ArticleIdList": ["10.1038/s12276-018-0111-4", "PMC6030094", "29968707"]}, {"Citation": "Chung Y.C., Baek J.Y., Kim S.R., Ko H.W., Bok E., Shin W.-H., Won S.-Y., Jin B.K. Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Exp. Mol. Med. 2017 49:e298. doi: 10.1038/emm.2016.159. Available online:  https://pubmed.ncbi.nlm.nih.gov/28255166/", "ArticleIdList": ["10.1038/emm.2016.159", "PMC5382554", "28255166"]}, {"Citation": "Kim B., Koppula S., Kumar H., Park J.-Y., Kim I.-W., More S.V., Kim I.-S., Han S.-D., Kim S.-K., Yoon S.-H., et al.  \u03b1-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Neuropharmacology. 2015 97:46\u201357. doi: 10.1016/j.neuropharm.2015.04.037. Available online:  https://pubmed.ncbi.nlm.nih.gov/25983275/", "ArticleIdList": ["10.1016/j.neuropharm.2015.04.037", "25983275"]}, {"Citation": "Kim M.E., Park P.R., Na J.Y., Jung I., Cho J.H., Lee J.S. Anti-neuroinflammatory effects of galangin in LPS-stimulated BV-2 microglia through regulation of IL-1\u03b2 production and the NF-\u03baB signaling pathways.  [(accessed on 26 December 2021)];Mol. Cell Biochem. 2019 451:145\u2013153. doi: 10.1007/s11010-018-3401-1. Available online:  https://pubmed.ncbi.nlm.nih.gov/29995265/", "ArticleIdList": ["10.1007/s11010-018-3401-1", "29995265"]}, {"Citation": "Chen G., Liu J., Jiang L., Ran X., He D., Li Y., Huang B., Wang W., Fu S. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson\u2019s Disease in Rats.  [(accessed on 26 December 2021)];Int. J. Mol. Sci. 2017 19:12.  doi: 10.3390/ijms19010012. Available online:  https://pubmed.ncbi.nlm.nih.gov/29267220/", "ArticleIdList": ["10.3390/ijms19010012", "PMC5795964", "29267220"]}, {"Citation": "Wang J., He C., Wu W.-Y., Chen F., Li W.-Z., Chen H.-Q., Yin Y.-Y. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Pharmacol. Biochem. Behav. 2015 138:96\u2013103. doi: 10.1016/j.pbb.2015.09.013. Available online:  https://pubmed.ncbi.nlm.nih.gov/26394281/", "ArticleIdList": ["10.1016/j.pbb.2015.09.013", "26394281"]}, {"Citation": "Zhang X., Yang Y., Du L., Zhang W., Du G. Baicalein exerts anti-neuroinflammatory effects to protect against rotenone-induced brain injury in rats.  [(accessed on 26 December 2021)];Int. Immunopharmacol. 2017 50:38\u201347. doi: 10.1016/j.intimp.2017.06.007. Available online:  https://pubmed.ncbi.nlm.nih.gov/28623717/", "ArticleIdList": ["10.1016/j.intimp.2017.06.007", "28623717"]}, {"Citation": "Hou L., Sun F., Huang R., Sun W., Zhang D., Wang Q. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson\u2019s disease model.  [(accessed on 26 December 2021)];Redox. Biol. 2019 22:101134. doi: 10.1016/j.redox.2019.101134. Available online:  https://pubmed.ncbi.nlm.nih.gov/30798073/", "ArticleIdList": ["10.1016/j.redox.2019.101134", "PMC6389731", "30798073"]}, {"Citation": "Hu Z., Wang W., Ling J., Jiang C. \u03b1-Mangostin Inhibits \u03b1-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity.  [(accessed on 26 December 2021)];Cell Mol. Neurobiol. 2016 36:811\u2013820. doi: 10.1007/s10571-015-0264-9. Available online:  https://pubmed.ncbi.nlm.nih.gov/27002719/", "ArticleIdList": ["10.1007/s10571-015-0264-9", "PMC4894924", "27002719"]}, {"Citation": "Nava C.M., Acero G., Pedraza-Chaverri J., Fragoso G., Govezensky T., Gevorkian G. Alpha-mangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J mice.  [(accessed on 26 December 2021)];J. Neuroimmunol. 2016 297:20\u201327. doi: 10.1016/j.jneuroim.2016.05.008. Available online:  https://pubmed.ncbi.nlm.nih.gov/27397072/", "ArticleIdList": ["10.1016/j.jneuroim.2016.05.008", "27397072"]}, {"Citation": "Huang B., Liu J., Ma D., Chen G., Wang W., Fu S. Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson\u2019s disease model. J. Funct. Foods. 2018;45:452\u2013461. doi: 10.1016/j.jff.2018.04.018.", "ArticleIdList": ["10.1016/j.jff.2018.04.018"]}, {"Citation": "Kim H.D., Jeong K.H., Jung U.J., Kim S.R. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.  [(accessed on 26 December 2021)];J. Med. Food. 2016 19:374\u2013382. doi: 10.1089/jmf.2015.3581. Available online:  https://pubmed.ncbi.nlm.nih.gov/26991235/", "ArticleIdList": ["10.1089/jmf.2015.3581", "26991235"]}, {"Citation": "Wang G.-Q., Li D.-D., Huang C., Lu D.-S., Zhang C., Zhou S.-Y., Liu J., Zhang F. Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro. Front. Mol. Neurosci. 2018;10:441. doi: 10.3389/fnmol.2017.00441.", "ArticleIdList": ["10.3389/fnmol.2017.00441", "PMC5767257", "29375304"]}, {"Citation": "Cui Y., Wu J., Jung S.C., Park D.B., Maeng Y.H., Hong J.Y., Kim S.J., Lee S.R., Kim S.J., Kim S.J., et al.  Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation.  [(accessed on 26 December 2021)];Biol. Pharm. Bull. 2010 33:1814\u20131821. doi: 10.1248/bpb.33.1814. Available online:  https://pubmed.ncbi.nlm.nih.gov/21048305/", "ArticleIdList": ["10.1248/bpb.33.1814", "21048305"]}, {"Citation": "Jeong K.H., Jeon M.-T., Kim H.D., Jung U.J., Jang M.C., Chu J.W., Yang S.J., Choi I.Y., Choi M.-S., Kim S.R. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];J. Med. Food. 2015 18:409\u2013414. doi: 10.1089/jmf.2014.3241. Available online:  https://pubmed.ncbi.nlm.nih.gov/25325362/", "ArticleIdList": ["10.1089/jmf.2014.3241", "25325362"]}, {"Citation": "Wang S., Jing H., Yang H., Liu Z., Guo H., Chai L., Hu L. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];J. Ethnopharmacol. 2015 164:247\u2013255. doi: 10.1016/j.jep.2015.01.042. Available online:  https://pubmed.ncbi.nlm.nih.gov/25666429/", "ArticleIdList": ["10.1016/j.jep.2015.01.042", "25666429"]}, {"Citation": "Zhou J., Qu X.-D., Li Z.-Y., Ji W., Liu Q., Ma Y.-H., He J.-J. Salvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson\u2019s disease models.  [(accessed on 26 December 2021)];PLoS ONE. 2014 9:e101668.  doi: 10.1371/journal.pone.0101668. Available online:  https://pubmed.ncbi.nlm.nih.gov/24991814/", "ArticleIdList": ["10.1371/journal.pone.0101668", "PMC4081637", "24991814"]}, {"Citation": "Huang B., Liu J., Ju C., Yang D., Chen G., Xu S., Fu S. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide [LPS]-Induced Parkinson\u2019s Disease Models.  [(accessed on 26 December 2021)];Int. J. Mol. Sci. 2017 18:2043.  Available online:  https://pubmed.ncbi.nlm.nih.gov/28937602/", "ArticleIdList": ["PMC5666725", "28937602"]}, {"Citation": "Jing H., Wang S., Wang M., Fu W., Zhang C., Xu D. Isobavachalcone Attenuates MPTP-Induced Parkinson\u2019s Disease in Mice by Inhibition of Microglial Activation through NF-\u03baB Pathway.  [(accessed on 26 December 2021)];PLoS ONE. 2017 12:e0169560.  doi: 10.1371/journal.pone.0169560. Available online:  https://pubmed.ncbi.nlm.nih.gov/28060896/", "ArticleIdList": ["10.1371/journal.pone.0169560", "PMC5217967", "28060896"]}, {"Citation": "Ma J., Hwang Y.K., Cho W.H., Han S.H., Hwang J.K., Han J.S. Macelignan attenuates activations of mitogen-activated protein kinases and nuclear factor kappa B induced by lipopolysaccharide in microglial cells.  [(accessed on 26 December 2021)];Biol. Pharm. Bull. 2009 32:1085\u20131090. doi: 10.1248/bpb.32.1085. Available online:  https://www.researchgate.net/publication/26254223_Macelignan_Attenuates_Activations_of_Mitogen-Activated_Protein_Kinases_and_Nuclear_Factor_kappa_B_Induced_by_Lipopolysaccharide_in_Microglial_Cells.", "ArticleIdList": ["10.1248/bpb.32.1085", "19483320"]}, {"Citation": "Kiyofuji K., Kurauchi Y., Hisatsune A., Seki T., Mishima S., Katsuki H. A natural compound macelignan protects midbrain dopaminergic neurons from inflammatory degeneration via microglial arginase-1 expression.  [(accessed on 26 December 2021)];Eur. J. Pharmacol. 2015 760:129\u2013135. doi: 10.1016/j.ejphar.2015.04.021. Available online:  https://pubmed.ncbi.nlm.nih.gov/25917324/", "ArticleIdList": ["10.1016/j.ejphar.2015.04.021", "25917324"]}, {"Citation": "Gao X.-Q., Du Z.-R., Yuan L.-J., Zhang W.-D., Chen L., Teng J.-J., Wong M.S., Xie J.-X., Chen W.-F. Ginsenoside Rg1 Exerts Anti-inflammatory Effects via G Protein-Coupled Estrogen Receptor in Lipopolysaccharide-Induced Microglia Activation. Front. Neurosci. 2019;13:1168. doi: 10.3389/fnins.2019.01168.", "ArticleIdList": ["10.3389/fnins.2019.01168", "PMC6853999", "31787867"]}, {"Citation": "Liu J.Q., Zhao M., Zhang Z., Cui L.Y., Zhou X., Zhang W., Chen N.H. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-\u03baB signaling and modulation of M1/M2 polarization.  [(accessed on 26 December 2021)];Acta Pharmacol. Sin. 2020 41:523\u2013534. doi: 10.1038/s41401-020-0358-x. Available online:  https://www.researchgate.net/publication/340129734_Rg1_improves_LPS-induced_Parkinsonian_symptoms_in_mice_via_inhibition_of_NF-kB_signaling_and_modulation_of_M1M2_polarization.", "ArticleIdList": ["10.1038/s41401-020-0358-x", "PMC7468333", "32203085"]}, {"Citation": "Pan X.-D., Chen X.-C., Zhu Y.-G., Zhang J., Huang T.-W., Chen L.-M., Ye Q.-Y., Huang H.-P. Neuroprotective role of tripchlorolide on inflammatory neurotoxicity induced by lipopolysaccharide-activated microglia.  [(accessed on 26 December 2021)];Biochem. Pharmacol. 2008 76:362\u2013372. doi: 10.1016/j.bcp.2008.05.018. Available online:  https://pubmed.ncbi.nlm.nih.gov/18602088/", "ArticleIdList": ["10.1016/j.bcp.2008.05.018", "18602088"]}, {"Citation": "Huang Y.-Y., Zhang Q., Zhang J.-N., Zhang Y.-N., Gu L., Yang H.-M., Xia N., Wang X.-M., Zhang H. Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];Brain Behav. Immun. 2018 71:93\u2013107. doi: 10.1016/j.bbi.2018.04.006. Available online:  https://pubmed.ncbi.nlm.nih.gov/29649522/", "ArticleIdList": ["10.1016/j.bbi.2018.04.006", "29649522"]}, {"Citation": "Kim H.D., Jeong K.H., Jung U.J., Kim S.R. Naringin treatment induces neuroprotective effects in a mouse model of Parkinson\u2019s disease in vivo, but not enough to restore the lesioned dopaminergic system. J. Nutr. Biochem. 2016;28:140\u2013146. doi: 10.1016/j.jnutbio.2015.10.013.", "ArticleIdList": ["10.1016/j.jnutbio.2015.10.013", "26878791"]}, {"Citation": "Leem E., Nam J., Jeon M.-T., Shin W.-H., Won S.-Y., Park S.-J., Choi M.-S., Jin B.K., Jung U.J., Kim S.R. Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson\u2019s disease.  [(accessed on 26 December 2021)];J. Nutr. Biochem. 2014 25:801\u2013806. doi: 10.1016/j.jnutbio.2014.03.006. Available online:  https://pubmed.ncbi.nlm.nih.gov/24797334/", "ArticleIdList": ["10.1016/j.jnutbio.2014.03.006", "24797334"]}, {"Citation": "Omeragic A., Kara-Yacoubian N., Kelschenbach J., Sahin C., Cummins C.L., Volsky D.J., Bendayan R. Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model.  [(accessed on 26 December 2021)];Sci. Rep. 2019 9:9428. doi: 10.1038/s41598-019-45878-6. Available online:  https://pubmed.ncbi.nlm.nih.gov/31263138/", "ArticleIdList": ["10.1038/s41598-019-45878-6", "PMC6603270", "31263138"]}, {"Citation": "Kim S.S., Lim J., Bang Y., Gal J., Lee S.U., Cho Y.C., Choi H.J. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: Therapeutic relevance to neurodegenerative disease. J. Nutr. Biochem. 2012;23:1314\u20131323. doi: 10.1016/j.jnutbio.2011.07.012.", "ArticleIdList": ["10.1016/j.jnutbio.2011.07.012", "22227268"]}, {"Citation": "Sawada M., Imamura K., Nagatsu T. Role of cytokines in inflammatory process in Parkinson\u2019s disease.  [(accessed on 26 December 2021)];J. Neural. Transm. Suppl. 2006 :373\u2013381. Available online:  https://pubmed.ncbi.nlm.nih.gov/17017556/", "ArticleIdList": ["17017556"]}, {"Citation": "Vlachou S., Nomikos G.G., Stephens D.N., Panagis G. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.  [(accessed on 26 December 2021)];Behav. Pharmacol. 2007 18:311\u2013319. doi: 10.1097/FBP.0b013e3282186cf2. Available online:  https://pubmed.ncbi.nlm.nih.gov/17551324/", "ArticleIdList": ["10.1097/FBP.0b013e3282186cf2", "17551324"]}, {"Citation": "Losseff N.A., Webb S.L., O\u2019Riordan J.I., Page R., Wang L., Barker G.J., Thompson A.J. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.  [(accessed on 26 December 2021)];Brain. 1996 119:701\u2013708. doi: 10.1093/brain/119.3.701. Available online:  https://pubmed.ncbi.nlm.nih.gov/8673483/", "ArticleIdList": ["10.1093/brain/119.3.701", "8673483"]}, {"Citation": "Rudick R.A. Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics.  [(accessed on 26 December 2021)];Arch. Neurol. 1999 56:1079\u20131084. doi: 10.1001/archneur.56.9.1079. Available online:  https://pubmed.ncbi.nlm.nih.gov/10488808/", "ArticleIdList": ["10.1001/archneur.56.9.1079", "10488808"]}, {"Citation": "Neuropsychological Effects of Interferon Beta-1a in Relapsing Multiple Sclerosis. Multiple Sclerosis Collaborative Research Group\u2014PubMed.  [(accessed on 26 December 2021)]; Available online:  https://pubmed.ncbi.nlm.nih.gov/11117545/"}, {"Citation": "Kasper L.H., Reder A.T. Immunomodulatory activity of interferon-beta.  [(accessed on 26 December 2021)];Ann. Clin. Transl. Neurol. 2014 1:622\u2013631. doi: 10.1002/acn3.84. Available online:  https://pubmed.ncbi.nlm.nih.gov/25356432/", "ArticleIdList": ["10.1002/acn3.84", "PMC4184564", "25356432"]}, {"Citation": "Solaro C., Trabucco E., Messmer U.M. Pain and multiple sclerosis: Pathophysiology and treatment.  [(accessed on 26 December 2021)];Curr. Neurol. Neurosci. Rep. 2013 13:320. doi: 10.1007/s11910-012-0320-5. Available online:  https://pubmed.ncbi.nlm.nih.gov/23250765/", "ArticleIdList": ["10.1007/s11910-012-0320-5", "23250765"]}, {"Citation": "Fu X., Wang Y., Wang C., Wu H., Li J., Li M., Ma Q., Yang W. A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: A systematic review and network meta-analysis. undefined. Clin. Rehabil. 2018;32:713\u2013721. doi: 10.1177/0269215517745348.", "ArticleIdList": ["10.1177/0269215517745348", "29582713"]}, {"Citation": "Peng H., Li H., Sheehy A., Cullen P., Allaire N., Scannevin R.H. Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.  [(accessed on 26 December 2021)];J. Neuroimmunol. 2016 299:35\u201344. doi: 10.1016/j.jneuroim.2016.08.006. Available online:  https://pubmed.ncbi.nlm.nih.gov/27725119/", "ArticleIdList": ["10.1016/j.jneuroim.2016.08.006", "27725119"]}, {"Citation": "Qin S.Y., Du R.H., Yin S.S., Liu X.F., Xu G.L., Cao W. Nrf2 is essential for the anti-inflammatory effect of carbon monoxide in LPS-induced inflammation.  [(accessed on 26 December 2021)];Inflamm. Res. 2015 64:537\u2013548. doi: 10.1007/s00011-015-0834-9. Available online:  https://pubmed.ncbi.nlm.nih.gov/26049867/", "ArticleIdList": ["10.1007/s00011-015-0834-9", "26049867"]}, {"Citation": "Foresti R., Bains S.K., Pitchumony T.S., De Castro Br\u00e1s L.E., Drago F., Dubois-Rand\u00e9 J.-L., Bucolo C., Motterlini R. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells.  [(accessed on 26 December 2021)];Pharm. Res. 2013 76:132\u2013148. doi: 10.1016/j.phrs.2013.07.010. Available online:  https://pubmed.ncbi.nlm.nih.gov/23942037/", "ArticleIdList": ["10.1016/j.phrs.2013.07.010", "23942037"]}, {"Citation": "Zhou J., Cai W., Jin M., Xu J., Wang Y., Xiao Y., Hao L., Wang B., Zhang Y., Han J., et al.  18\u03b2-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination.  [(accessed on 26 December 2021)];Sci. Rep. 2015 5:13713. doi: 10.1038/srep13713. Available online:  https://pubmed.ncbi.nlm.nih.gov/26329786/", "ArticleIdList": ["10.1038/srep13713", "PMC4557075", "26329786"]}, {"Citation": "Takeuchi H., Wang J., Kawanokuchi J., Mitsuma N., Mizuno T., Suzumura A. Interferon-gamma induces microglial-activation-induced cell death: A hypothetical mechanism of relapse and remission in multiple sclerosis.  [(accessed on 26 December 2021)];Neurobiol. Dis. 2006 22:33\u201339. doi: 10.1016/j.nbd.2005.09.014. Available online:  https://pubmed.ncbi.nlm.nih.gov/16386911/", "ArticleIdList": ["10.1016/j.nbd.2005.09.014", "16386911"]}, {"Citation": "Sun Y., Chen H., Dai J., Wan Z., Xiong P., Xu Y., Han Z., Chai W., Gong F., Zheng F. Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 [HMGB1] Expression and Neuronal HMGB1 Release. Front Immunol. 2018;9:1518. doi: 10.3389/fimmu.2018.01518.", "ArticleIdList": ["10.3389/fimmu.2018.01518", "PMC6036111", "30013568"]}, {"Citation": "A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis\u2014Study Results\u2014ClinicalTrials.Gov.  [(accessed on 26 December 2021)]; Available online:  https://clinicaltrials.gov/ct2/show/results/NCT01599234?view=results."}, {"Citation": "Rahimi A., Faizi M., Talebi F., Noorbakhsh F., Kahrizi F., Naderi N. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.  [(accessed on 26 December 2021)];Neuroscience. 2015 290:279\u2013287. doi: 10.1016/j.neuroscience.2015.01.030. Available online:  https://pubmed.ncbi.nlm.nih.gov/25637488/", "ArticleIdList": ["10.1016/j.neuroscience.2015.01.030", "25637488"]}, {"Citation": "Kronenberg J., Pars K., Brieskorn M., Prajeeth C.K., Heckers S., Schwenkenbecher P., Skripuletz T., Pul R., Pavlou A., Stangel M. Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia.  [(accessed on 26 December 2021)];Int. J. Mol. Sci. 2019 20:325.  doi: 10.3390/ijms20020325. Available online:  https://pubmed.ncbi.nlm.nih.gov/30650518/", "ArticleIdList": ["10.3390/ijms20020325", "PMC6358967", "30650518"]}, {"Citation": "Kuo P.-C., Brown D.A., Scofield B.A., Yu I.-C., Chang F.-L., Wang P.-Y., Yen J.-H. 3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.  [(accessed on 26 December 2021)];Brain Behav. Immun. 2016 57:173\u2013186. doi: 10.1016/j.bbi.2016.03.015. Available online:  https://pubmed.ncbi.nlm.nih.gov/27013356/", "ArticleIdList": ["10.1016/j.bbi.2016.03.015", "27013356"]}, {"Citation": "Zeng Y., Song C., Ding X., Ji X., Yi L., Zhu K. Baicalin reduces the severity of experimental autoimmune encephalomyelitis.  [(accessed on 26 December 2021)];Braz. J. Med. Biol. Res. 2007 40:1003\u20131010. doi: 10.1590/S0100-879X2006005000115. Available online:  https://www.researchgate.net/publication/6186224_Baicalin_reduces_the_severity_of_experimental_autoimmune_encephalomyelitis.", "ArticleIdList": ["10.1590/S0100-879X2006005000115", "17653455"]}, {"Citation": "Zhang Y., Li X., Ciric B., Abdolmohamad R., Gran B., Rostami A., Zhang G.-X. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.  [(accessed on 26 December 2021)];Sci. Rep. 2015 5:17407. doi: 10.1038/srep17407. Available online:  https://pubmed.ncbi.nlm.nih.gov/26616302/", "ArticleIdList": ["10.1038/srep17407", "PMC4663791", "26616302"]}, {"Citation": "Wang M.-R., Zhang X.-J., Liu H.-C., Ma W.-D., Zhang M.-L., Zhang Y., Li X., Dou M.-M., Jing Y.-L., Chu Y.-J., et al.  Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy.  [(accessed on 26 December 2021)];Brain Res. Bull. 2019 153:30\u201338. doi: 10.1016/j.brainresbull.2019.08.006. Available online:  https://pubmed.ncbi.nlm.nih.gov/31404585/", "ArticleIdList": ["10.1016/j.brainresbull.2019.08.006", "31404585"]}, {"Citation": "Mart\u00edn R., Hern\u00e1ndez M., C\u00f3rdova C., Nieto M.L. Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: Therapeutic implications for multiple sclerosis.  [(accessed on 26 December 2021)];Br. J. Pharmacol. 2012 166:1708. doi: 10.1111/j.1476-5381.2012.01869.x. Available online:  https://pmc/articles/PMC3419913/", "ArticleIdList": ["10.1111/j.1476-5381.2012.01869.x", "PMC3419913", "22260389"]}, {"Citation": "Mart\u00edn R., Carvalho-Tavares J., Hern\u00e1ndez M., Arn\u00e9s M., Ruiz-Guti\u00e9rrez V., Nieto M.L. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: A potential therapeutic role.  [(accessed on 26 December 2021)];Biochem. Pharmacol. 2010 79:198\u2013208. doi: 10.1016/j.bcp.2009.08.002. Available online:  https://pubmed.ncbi.nlm.nih.gov/19679109/", "ArticleIdList": ["10.1016/j.bcp.2009.08.002", "19679109"]}, {"Citation": "He Y., Du M., Gao Y., Liu H., Wang H., Wu X., Wang Z. Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels.  [(accessed on 26 December 2021)];PLoS ONE. 2013 8:e76495.  doi: 10.1371/journal.pone.0076495. Available online:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076495.", "ArticleIdList": ["10.1371/journal.pone.0076495", "PMC3790693", "24124567"]}, {"Citation": "Kamisli S., Ciftci O., Taslidere A.B., Turkmen N., Ozcan C. The beneficial effects of 18\u03b2-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis [EAE] in C57BL/6 mouse model.  [(accessed on 26 December 2021)];Immunopharmacol. Immunotoxicol. 2018 40:344\u2013352. doi: 10.1080/08923973.2018.1490318. Available online:  https://pubmed.ncbi.nlm.nih.gov/30052483/", "ArticleIdList": ["10.1080/08923973.2018.1490318", "30052483"]}, {"Citation": "Li X., Zhao L., Han J.-J., Zhang F., Liu S., Zhu L., Wang Z.-Z., Zhang G.-X., Zhang Y. Carnosol modulates Th17 cell differentiation and microglial switch in experimental autoimmune encephalomyelitis. Front. Immunol. 2018;9:1807. doi: 10.3389/fimmu.2018.01807.", "ArticleIdList": ["10.3389/fimmu.2018.01807", "PMC6100297", "30150982"]}, {"Citation": "Yan J., Yang X., Han D., Feng J. Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats.  [(accessed on 26 December 2021)];Mol. Med. Rep. 2016 14:1601\u20131609. doi: 10.3892/mmr.2016.5431. Available online:  https://pubmed.ncbi.nlm.nih.gov/27357729/", "ArticleIdList": ["10.3892/mmr.2016.5431", "PMC4940100", "27357729"]}, {"Citation": "Fung S., Cherry A.E., Xu C., Stella N. Alkylindole-sensitive receptors modulate microglial cell migration and proliferation.  [(accessed on 26 December 2021)];Glia. 2015 63:1797\u20131808. doi: 10.1002/glia.22845. Available online:  https://pubmed.ncbi.nlm.nih.gov/25914169/", "ArticleIdList": ["10.1002/glia.22845", "PMC4418235", "25914169"]}, {"Citation": "Heng B.C., Aubel D., Fussenegger M. An overview of the diverse roles of G-protein coupled receptors [GPCRs] in the pathophysiology of various human diseases.  [(accessed on 26 December 2021)];Biotechnol. Adv. 2013 31:1676\u20131694. doi: 10.1016/j.biotechadv.2013.08.017. Available online:  https://pubmed.ncbi.nlm.nih.gov/23999358/", "ArticleIdList": ["10.1016/j.biotechadv.2013.08.017", "23999358"]}, {"Citation": "Guerram M., Zhang L.Y., Jiang Z.Z. G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases.  [(accessed on 26 December 2021)];Neurochem. Int. 2016 101:1\u201314. doi: 10.1016/j.neuint.2016.09.005. Available online:  https://pubmed.ncbi.nlm.nih.gov/27620813/", "ArticleIdList": ["10.1016/j.neuint.2016.09.005", "27620813"]}, {"Citation": "Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.  [(accessed on 26 December 2021)];Glia. 2010 58:1017\u20131030. doi: 10.1002/glia.20983. Available online:  https://pubmed.ncbi.nlm.nih.gov/20468046/", "ArticleIdList": ["10.1002/glia.20983", "PMC2919281", "20468046"]}, {"Citation": "Schilling T., Eder C. Microglial K [+] channel expression in young adult and aged mice.  [(accessed on 26 December 2021)];Glia. 2015 63:664\u2013672. doi: 10.1002/glia.22776. Available online:  https://pubmed.ncbi.nlm.nih.gov/25472417/", "ArticleIdList": ["10.1002/glia.22776", "PMC4359010", "25472417"]}, {"Citation": "Hashioka S., Klegeris A., McGeer P.L. Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers.  [(accessed on 26 December 2021)];Neuropharmacology. 2012 63:685\u2013691. doi: 10.1016/j.neuropharm.2012.05.033. Available online:  https://pubmed.ncbi.nlm.nih.gov/22659089/", "ArticleIdList": ["10.1016/j.neuropharm.2012.05.033", "22659089"]}, {"Citation": "Richardson J.R., Hossain M.M. Microglial ion channels as potential targets for neuroprotection in Parkinson\u2019s disease. Neural. Plast. 2013;2013:587418. doi: 10.1155/2013/587418.", "ArticleIdList": ["10.1155/2013/587418", "PMC3832972", "24288626"]}, {"Citation": "Eder C. Regulation of microglial behavior by ion channel activity.  [(accessed on 26 December 2021)];J. Neurosci. Res. 2005 81:314\u2013321. doi: 10.1002/jnr.20476. Available online:  https://pubmed.ncbi.nlm.nih.gov/15929071/", "ArticleIdList": ["10.1002/jnr.20476", "15929071"]}, {"Citation": "Lee S.H., Suk K. Emerging roles of protein kinases in microglia-mediated neuroinflammation.  [(accessed on 26 December 2021)];Biochem. Pharmacol. 2017 146:1\u20139. doi: 10.1016/j.bcp.2017.06.137. Available online:  https://pubmed.ncbi.nlm.nih.gov/28684305/", "ArticleIdList": ["10.1016/j.bcp.2017.06.137", "28684305"]}, {"Citation": "Leung C.H., Grill S.P., Lam W., Han Q.B., Sun H.D., Cheng Y.C. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens.  [(accessed on 26 December 2021)];Mol. Pharmacol. 2005 68:286\u2013297. doi: 10.1124/mol.105.012765. Available online:  https://pubmed.ncbi.nlm.nih.gov/15872117/", "ArticleIdList": ["10.1124/mol.105.012765", "15872117"]}, {"Citation": "Goldmann T., Wieghofer P., M\u00fcller P.-F., Wolf Y., Varol D., Yona S., Brendecke S.M., Kierdorf K., Staszewski O., Datta M., et al.  A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.  [(accessed on 26 December 2021)];Nat. Neurosci. 2013 16:1618\u20131626. doi: 10.1038/nn.3531. Available online:  https://pubmed.ncbi.nlm.nih.gov/24077561/", "ArticleIdList": ["10.1038/nn.3531", "24077561"]}, {"Citation": "Choi M.J., Lee E.J., Park J.S., Kim S.N., Park E.M., Kim H.S. Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: Critical role of PPAR-\u03b3 signaling pathway.  [(accessed on 26 December 2021)];Biochem. Pharmacol. 2017 144:120\u2013131. doi: 10.1016/j.bcp.2017.07.021. Available online:  https://pure.ewha.ac.kr/en/publications/anti-inflammatory-mechanism-of-galangin-in-lipopolysaccharide-sti.", "ArticleIdList": ["10.1016/j.bcp.2017.07.021", "28757373"]}, {"Citation": "Lehtonen \u0160., Sonninen T.M., Wojciechowski S., Goldsteins G., Koistinaho J. Dysfunction of cellular proteostasis in Parkinson\u2019s disease. Front. Neurosci. 2019;13:457. doi: 10.3389/fnins.2019.00457.", "ArticleIdList": ["10.3389/fnins.2019.00457", "PMC6524622", "31133790"]}, {"Citation": "Kim N., Lee H.J. Target Enzymes Considered for the Treatment of Alzheimer\u2019s Disease and Parkinson\u2019s Disease. Biomed. Res. Int. 2020;2020:2010728. doi: 10.1155/2020/2010728.", "ArticleIdList": ["10.1155/2020/2010728", "PMC7669341", "33224974"]}, {"Citation": "Schreibelt G., van Horssen J., van Rossum S., Dijkstra C.D., Drukarch B., de Vries H.E. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology.  [(accessed on 26 December 2021)];Brain Res. Rev. 2007 56:322\u2013330. doi: 10.1016/j.brainresrev.2007.07.005. Available online:  https://pubmed.ncbi.nlm.nih.gov/17761296/", "ArticleIdList": ["10.1016/j.brainresrev.2007.07.005", "17761296"]}, {"Citation": "Thangudu S., Cheng F.Y., Su C.H. Advancements in the Blood\u2013Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications.  [(accessed on 26 December 2021)];Polymers. 2020 12:3055.  doi: 10.3390/polym12123055. Available online:  https://www.mdpi.com/2073-4360/12/12/3055/htm.", "ArticleIdList": ["10.3390/polym12123055", "PMC7766280", "33419339"]}, {"Citation": "Alghamdi S.S., Suliman R.S., Almutairi K., Kahtani K., Aljatli D. Imidazole as a Promising Medicinal Scaffold: Current Status and Future Direction.  [(accessed on 26 December 2021)];Drug Des. Devel. Ther. 2021 15:3289\u20133312. doi: 10.2147/DDDT.S307113. Available online:  https://pubmed.ncbi.nlm.nih.gov/34354342/", "ArticleIdList": ["10.2147/DDDT.S307113", "PMC8329171", "34354342"]}, {"Citation": "Feng X.L., Yu Y., Qin D.P., Gao H., Yao X.S. Acorus Linnaeus: A review of traditional uses, phytochemistry and neuropharmacology.  [(accessed on 26 December 2021)];RSC Adv. 2014 5:5173\u20135182. doi: 10.1039/C4RA12049C. Available online:  https://pubs.rsc.org/en/content/articlehtml/2015/ra/c4ra12049c.", "ArticleIdList": ["10.1039/C4RA12049C"]}, {"Citation": "Bors L.A., Erd\u00f6 F. Overcoming the Blood\u2013Brain Barrier. Challenges and Tricks for CNS Drug Delivery.  [(accessed on 26 December 2021)];Sci. Pharm. 2019 87:6.  doi: 10.3390/scipharm87010006. Available online:  https://www.mdpi.com/2218-0532/87/1/6/htm.", "ArticleIdList": ["10.3390/scipharm87010006"]}, {"Citation": "Kahraman C., Arituluk Z.C., Irem I., Cankaya T. The Clinical Importance of Herb-Drug Interactions and Toxicological Risks of Plants and Herbal Products.  [(accessed on 26 December 2021)];Med. Toxicol. 2020 :1\u201331. Available online:  https://www.intechopen.com/chapters/71771."}, {"Citation": "Yang H., Sun L., Li W., Liu G., Tang Y. In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts. Front. Chem. 2018;20:30. doi: 10.3389/fchem.2018.00030.", "ArticleIdList": ["10.3389/fchem.2018.00030", "PMC5826228", "29515993"]}, {"Citation": "Way2Drug\u2014Main.  [(accessed on 25 May 2021)].  Available online:  http://way2drug.com/PassOnline/"}, {"Citation": "Molinspiration Cheminformatics.  [(accessed on 26 December 2021)].  Available online:  https://www.molinspiration.com/"}, {"Citation": "Swiss ADME.  [(accessed on 8 November 2021)].  Available online:  http://www.swissadme.ch/"}, {"Citation": "ProTox-II\u2014Prediction of TOXicity of Chemicals.  [(accessed on 8 November 2021)].  Available online:  https://tox-new.charite.de/protox_II/"}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "16"}, {"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "2", "Day": "15"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "1", "Minute": "4"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["35214883", "PMC8878483", "10.3390/plants11040549", "plants11040549"]}}], "PubmedBookArticle": []}